Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$105.28 - $135.9 $3.65 Million - $4.72 Million
-34,700 Reduced 45.78%
41,100 $5.36 Million
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $7.66 Million - $10.1 Million
75,800 New
75,800 $7.91 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $14 Million - $21.6 Million
151,400 New
151,400 $21.1 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $3.67 Million - $4.65 Million
-20,000 Reduced 50.0%
20,000 $3.75 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $716,875 - $860,435
-3,700 Reduced 8.47%
40,000 $9.3 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $2.12 Million - $2.74 Million
-11,300 Reduced 20.55%
43,700 $8.84 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $9.75 Million - $12.5 Million
55,000 New
55,000 $10.5 Million
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $2.28 Million - $3.18 Million
7,500 Added 33.33%
30,000 $10.5 Million
Q3 2021

Nov 12, 2021

BUY
$405.61 - $524.84 $9.13 Million - $11.8 Million
22,500 New
22,500 $9.13 Million
Q2 2021

Aug 16, 2021

SELL
$372.84 - $481.5 $10.1 Million - $13 Million
-27,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $9.75 Million - $13.6 Million
27,000 New
27,000 $10.4 Million
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $14.6 Million - $23.5 Million
-70,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$288.29 - $335.49 $20.2 Million - $23.5 Million
70,000 New
70,000 $23.2 Million
Q1 2019

May 14, 2019

SELL
$272.57 - $321.18 $5.4 Million - $6.36 Million
-19,800 Closed
0 $0
Q4 2018

Jan 30, 2019

BUY
$272.46 - $366.54 $5.39 Million - $7.26 Million
19,800 New
19,800 $5.94 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.